Sanofi (SNY) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sanofi

    NASDAQ: SNY · Real-Time Price · USD
    47.16
    -0.29 (-0.61%)
    At close: Sep 10, 2025, 3:59 PM
    47.36
    0.42%
    Pre-market: Sep 11, 2025, 04:37 AM EDT

    Sanofi Balance Sheet Statement

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 7.44B 8.71B 12.74B 10.1B
    Short-Term Investments
    		 486M n/a n/a n/a
    Long-Term Investments
    		 3.26B 3.26B 3.22B 2.91B
    Other Long-Term Assets
    		 1.37B 588M 882M 731M
    Receivables
    		 10.63B 11.04B 10.75B 9.79B
    Inventory
    		 9.43B 9.67B 8.96B 8.71B
    Other Current Assets
    		 13.71B 471M 870M 1.35B
    Total Current Assets
    		 42.59B 30.66B 34.03B 30.56B
    Property-Plant & Equipment
    		 11.6B 11.81B 11.68B 11.98B
    Goodwill & Intangibles
    		 66.01B 73.72B 71.53B 69.46B
    Total Long-Term Assets
    		 90.21B 95.81B 92.7B 89.68B
    Total Assets
    		 132.8B 126.46B 126.72B 120.24B
    Account Payables
    		 7.55B 7.33B 6.81B 6.18B
    Deferred Revenue
    		 n/a n/a 264M 319M
    Short-Term Debt
    		 4.21B 2.32B 4.45B 3.45B
    Other Current Liabilities
    		 17.14B 11.84B 11.86B 10.61B
    Total Current Liabilities
    		 29.16B 24.19B 23.96B 21.3B
    Long-Term Debt
    		 11.79B 14.35B 14.86B 17.12B
    Other Long-Term Liabilities
    		 10.18B 9.96B 9B 9.34B
    Total Long-Term Liabilities
    		 25.78B 27.92B 27.61B 29.92B
    Total Liabilities
    		 54.94B 52.11B 51.57B 51.21B
    Total Debt
    		 17.91B 18.42B 21.21B 22.41B
    Common Stock
    		 2.53B 2.53B 2.52B 2.53B
    Retained Earnings
    		 n/a 67.5B 66.73B 63.01B
    Comprehensive Income
    		 70.56B 4.88B 6.11B 3.55B
    Shareholders Equity
    		 77.51B 74.04B 74.78B 68.68B
    Total Investments
    		 3.75B 3.26B 3.22B 2.91B

    Add to Watchlist